Home

Moleculin Biotech, Inc. - Common Stock (MBRX)

0.8020
-0.0336 (-4.02%)
NASDAQ · Last Trade: Jul 19th, 3:14 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Moleculin Biotech (NASDAQ:MBRX) Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team
Moleculin CEO, Walter Klemp highlights Annamycin differentiation in the current AML treatment landscape and potential opportunity
Via ACCESSWIRE · April 25, 2024
JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th
- Live video webcast presentations with participating companies -
Via ACCESSWIRE · January 11, 2023
JTC Team to Host Virtual Investor 2022 Top Picks Conference on January 25th, 26th, and 27th
- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast presentations of participating companies followed by interactive Q&A session - PITTSTOWN, NJ / ACCESSWIRE / January 12, 2022 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor 2022 Top Picks Conference January 25-27, 2022. As part of the virtual
By JTC Team, LLC · Via AccessWire · January 12, 2022
JTC Team to Host Virtual Investor Roundtable Event on November 16th, 17th, and 18th
- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast roundtable discussions with members of Management and Thought Leaders across participating companies - PITTSTOWN, NJ / ACCESSWIRE / November 4, 2021 / November 4, 2021 - JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor Roundtable Event November 16-18,
By JTC Team, LLC · Via AccessWire · November 4, 2021